Home
Clinical Trials
Usage and Plan of Care Change...

Usage and Plan of Care Changes Due to Drug Screenings

Last Updated: 2019-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-31

Study Completion Date

2020-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this minimal risk, observational survey is to document the accuracy, benefits, and how qualitative and quantitative results affect patients' plan of care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Strategy to Reduce Opioid Drug Prescribing by Clinicians

NCT03809507

Analgesics Opioid

COMPLETED

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

NCT00225797

Chronic Pain

COMPLETED PHASE3

Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

NCT02469077

Chronic Pain

COMPLETED NA

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

NCT00485225

Chronic, Non Malignant Pain

COMPLETED PHASE2

Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes

NCT02932579

Pain

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pain is the most common reason patients consult primary care providers. According to recent surveys, One in six Americans live with chronic or recurrent pain and pay an estimated $120 billion a year in medical costs in the United States. Oral opioids are the common treatment options for various chronic pains including joint pain, musculoskeletal pain, neuropathic pain and migraines. This narcotic-based management of pain is often associated with undesirable side effects with addictive and potential abuse.

To ensure proper usage of prescribed medications, physicians use drug screens to monitor therapeutic levels and test for presence of illegal drugs or medications that may cause a drug-drug interaction. Upon receiving quantitative or qualitative results from these drug screens, the physician may change the treatment plan for patients to improve efficacy of prescribed medications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Does not include a drug needing FDA approval and therefore it is not by definition, a Clinical Drug Trial as defined by FDA.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be a Medical Practioner

* Medical Doctor (MD)
* Doctor of Osteopathic (DO)
* Physician Assistant (PA)
* Advanced Practice Registered Nurse (APRN)
* Nurse Practioner (NP)
* Must have a current standard operating procedure that includes obtaining/reviewing medical history.